Skip to main content
Clinical Trials/DRKS00012888
DRKS00012888
Not yet recruiting
未知

Treatment strategies for Medication-related osteonecrosis of the jaw - a prospective, partially randomized patient preference trial - TEAM

Klinik und Poliklinik für Mund-, Kiefer- & Gesichtschirurgie, Universitätsklinikum Heidelberg, Ärztlicher Direktor: Prof. Dr. Dr. Jürgen Hoffmann0 sites90 target enrollmentMay 17, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Medication-related osteonecrosis of the jaw
Sponsor
Klinik und Poliklinik für Mund-, Kiefer- & Gesichtschirurgie, Universitätsklinikum Heidelberg, Ärztlicher Direktor: Prof. Dr. Dr. Jürgen Hoffmann
Enrollment
90
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 17, 2018
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Klinik und Poliklinik für Mund-, Kiefer- & Gesichtschirurgie, Universitätsklinikum Heidelberg, Ärztlicher Direktor: Prof. Dr. Dr. Jürgen Hoffmann

Eligibility Criteria

Inclusion Criteria

  • Patients with not infected medication\-related osteonecrosis of the jaw (stadium I corresponding to AAOMS classification) who receiced or are receiving antiresorptive therapy (bisphosphonates or RANKL antibody) and who are planned for treatment at Clinic for craniofacial surgery of University hospital Heidelberg

Exclusion Criteria

  • 1\. Previous history of a radiation to the head neck region 2\. Known metastasis of the jaw

Outcomes

Primary Outcomes

Not specified

Similar Trials